Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–19 of 19 trials
Active filters
Clinical trials found
Published and searchable clinical trials
Searching for clinical trials...
NCT04222413
- Conditions
- Advanced Breast Cancer, Advanced Solid Tumors, Colonic Diseases, +32 more
- Locations
-
- University of Kansas Fairway, Kansas, United States
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
Recruiting
Natural History and Biospecimen Acquisition for Children and Adults With Rare Solid Tumors
NCT03739827
- Conditions
- Malignant Solid Tumors, Other Neoplasms Solid Tumors, Pediatric Solid Tumor, +2 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
- Oregon Health and Science University Portland, Oregon, United States
- Texas Children's Hospital Houston, Texas, United States
NCT05521984
- Conditions
- Pediatric Brain Tumor, Pediatric Solid Tumor
- Locations
-
- Washington University School of Medicine/St. Louis Children's Hospital St Louis, Missouri, United States
NCT05151718
- Conditions
- Ependymoma of Brain, Familial ependymoma, Pediatric Solid Tumor
- Locations
-
- Institut Claudius Regaud Toulouse, France
NCT05468359
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +15 more
- Locations
-
- Methodist Le Bonheur Healthcare Germantown, Tennessee, United States
- St. Jude Children's Research Hospital Memphis, Tennessee, United States
NCT04897321
- Conditions
- Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, Adrenal Gland Diseases, +65 more
- Locations
-
- St. Jude Children's Research Hospital Memphis, Tennessee, United States
NCT06760117
- Conditions
- Pediatric Solid Tumor
- Locations
-
- Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China
Not Yet Recruiting
B7-H3.CD28Z.CART in Solid Tumors
NCT07358260
- Conditions
- Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +8 more
- Locations
-
- Dana Farber Cancer Institite Boston, Massachusetts, United States
Completed
A Study Evaluating the Safety and Activity of Pegylated Recombinant Human Arginase (BCT-100)
NCT03455140
- Conditions
- Cancer, Hematologic Diseases, Hemic and Lymphatic Diseases, +12 more
- Locations
-
- Women's & Children's Hospital Adelaide, Australia
- Queensland Children's Hospital Brisbane, Australia
- Royal Children's Hospital Melbourne Melbourne, Australia
- Perth Children's Hospital Perth, Australia
Completed
A Prediction Model of Hematological Recovery After High-dose Chemotherapy in Pediatric Solid Tumor
NCT05024331
- Conditions
- Neoplasms, Pediatric Solid Tumor
- Locations
-
- Samsung Medical Centre Seoul, South Korea
NCT02564198
- Conditions
- CNS Malignancies, Central Nervous System Neoplasms, Disease Attributes, +10 more
- Locations
-
- Childrens Hospital of Alabama Birmingham, Alabama, United States
- Children's Oncology Group Monrovia, California, United States
- Childrens Hospital of Orange County Orange, California, United States
- University of California, San Francisco San Francisco, California, United States
NCT04944875
- Conditions
- Neoplasms, Pediatric Brain Tumor, Pediatric Cancer, +1 more
- Locations
-
- Özlem Öz Gergin Kayseri, Turkey (Türkiye)
NCT03222258
- Conditions
- Biliary Cancer Metastatic, Breast Diseases, Breast Neoplasms, +40 more
- Locations
-
- National Cancer Center, Korea Goyang-si, Gyeonggi-do, South Korea
- Seoul National University Bundang Hospital Seongnam-si, Gyeonggi-do, South Korea
- Gyeongsang National University Hospital Jinju, Gyeongsangnam-do, South Korea
- Chonbuk National University Hospital Jeonju, Jeollabuk-do, South Korea
NCT01853345
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Disease Attributes, Female Urogenital Diseases, +29 more
- Locations
-
- University of California, San Francisco San Francisco, California, United States
- Children's National Medical center Washington D.C., District of Columbia, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
- Boston Children's Hospital Boston, Massachusetts, United States
Active, Not Recruiting
B7H3 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults
NCT04483778
- Conditions
- Carcinoma, Clear Cell Sarcoma, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +66 more
- Locations
-
- Seattle Children's Hospital Seattle, Washington, United States
Active, Not Recruiting
The iCat2, GAIN (Genomic Assessment Informs Novel Therapy) Consortium Study
NCT02520713
- Conditions
- Pediatric Solid Tumor
- Locations
-
- University of California San Francisco San Francisco, California, United States
- Children's Hospital Colorado Aurora, Colorado, United States
- Children's National Medical Center Washington D.C., District of Columbia, United States
- University of Chicago Comer Children's Hospital Chicago, Illinois, United States
Active, Not Recruiting
Dose Escalation Study of CLR 131 in Pediatric Relapsed/Refractory Malignant Tumors Including Neuroblastoma and Sarcomas
NCT03478462
- Conditions
- Astrocytoma, Brain Diseases, Brain Neoplasms, +62 more
- Locations
-
- Lucile Packard Children's Hospital Palo Alto, California, United States
- Memorial Sloan Kettering Cancer Center New York, United States
- Duke University Chapel Hill, North Carolina, United States
- Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States
Active, Not Recruiting
EGFR806 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults
NCT03618381
- Conditions
- Carcinoma, Clear Cell Sarcoma, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +60 more
- Locations
-
- Seattle Children's Hospital Seattle, Washington, United States
Active, Not Recruiting
Phase I Dose Escalation and Pharmacokinetics Clinical Trial of Mitoxantrone Hydrochloride Liposome in Children With Relapsed and Refractory Lymphoma and Solid Tumors
NCT05620862
- Conditions
- Pediatric Solid Tumor
- Locations
-
- Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China